ASAlaser 2017: growth +13%

15 February 2018 - Corporate -

2017 overtakes the already significant 2016 result by 13% for ASAlaser, whose key pillars consist in research, internationalisation and training. In order to reach this objective, the company has also increased its staff by 20% and further increases are forecast during the year. “People represent a primary asset for us – explains Roberto Marchesini, CEO of ASAlaser – this is why investing in internal staff training is mandatory for us”. This is also confirmed by the figures: more than 2000 hours of training were provided during 2017, structured in group and one-to-one courses. 

Finally, funds for Research also ensure continuity: in 2016 the Company allocated approximately 13.5% of the turnover, which was increased to 14% in 2017. “To date, there are more than 150 scientific studies in the fields of research and clinical trials promoted by ASA. On average every year – explains Lucio Zaghetto, the Scientific & Educational Director – there are 6/7 basic and clinical research programmes, with an average length of 2-3 years, conducted directly by ASAcampus staff (the ASAlaser research division, ed.) and the same commitment is also scheduled for this year”. For the company, a year which will be in the name of the recognition of the innovative TT therapeutic strategy and of the HIRO TT device – successfully presented at “MEDICA 2017- World Forum for medicine” – and of the development of further therapeutic solutions. “2018 – previews Marchesini – will also be the year during which we will lay the foundations of the new production site, suitable for ensuring the best quality of work to all our employees”.

You might also be interested in ...

See all articles

ASAlaser Indonesia - IGNITE
News - 31/03/2026
The collaboration between ASAlaser and GEA Medical Indonesia marks a strategic step in the expansion of advanced laser therapy within a rapidly growing healthcare market.
ASAlaser LATAM Sales Meeting 2026
News - 30/03/2026
ASA recently organised the Sales Meeting for the LATAM area at the NH Collection hotel in Barranquilla, assembling distributors from throughout Latin America. The event represented an important...
M-Hi All Terrain
News - 12/03/2025
M-Hi All Terrain redefines the standards of MLS® Laser Therapy, combining portability, resistance and operational autonomy to offer effective treatments anywhere.
MiS laser-assisted wound care on a leech
Blog - 21/04/2026
The management of complex wounds remains a significant clinical challenge, especially in cases of tissue loss, deep burns, or chronic conditions. Conventional treatments require repeated...
Press - 07/04/2026
New scientific evidence supports the use of ASAveterinary's MLS® technology in the management of complex musculoskeletal disorders in veterinary medicine. Two studies, conducted in collaboration with...
ASAlaser Indonesia - IGNITE
News - 31/03/2026
The collaboration between ASAlaser and GEA Medical Indonesia marks a strategic step in the expansion of advanced laser therapy within a rapidly growing healthcare market.